UBS Group’s SANGRIX INC. Class A Ordinary Shares SGRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.93K | Buy |
469
+209
| +80% | +$2.08K | ﹤0.01% | 9262 |
|
|
2026
Q1 | $2.91K | Buy |
260
+208
| +400% | +$4.46K | ﹤0.01% | 9179 |
|
|
2025
Q4 | $2.69K | Sell |
52
-1,810
| -97% | -$169K | ﹤0.01% | 9251 |
|
|
2025
Q3 | $214K | Buy |
1,862
+1,648
| +770% | +$204K | ﹤0.01% | 6634 |
|
|
2025
Q2 | $10.1K | Buy |
+214
| New | +$10.4K | ﹤0.01% | 8855 |
|
|
2025
Q1 | – | Sell |
-400
| Closed | -$57.7K | – | 10095 |
|
|
2024
Q4 | $118K | Buy |
400
+371
| +1,279% | +$179K | ﹤0.01% | 6773 |
|
|
2024
Q3 | $17.9K | Sell |
29
-85
| -75% | -$49.3K | ﹤0.01% | 7433 |
|
|
2024
Q2 | $98.4K | Buy |
114
+109
| +2,180% | +$123K | ﹤0.01% | 6170 |
|
|
2024
Q1 | $6.34K | Sell |
5
-115
| -96% | -$161K | ﹤0.01% | 7467 |
|
|
2023
Q4 | $149K | Buy |
+120
| New | +$103K | ﹤0.01% | 5949 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 9373 |
|
|
2023
Q2 | – | Sell |
-1
| Closed | -$1.24K | – | 8418 |
|
|
2023
Q1 | $1.68K | Sell |
1
-2
| -67% | -$4.66K | ﹤0.01% | 8675 |
|
|
2022
Q4 | $4.22K | Hold |
3
| – | – | ﹤0.01% | 9359 |
|
|
2022
Q3 | $10K | Buy |
3
+1
| +50% | +$3.55K | ﹤0.01% | 8406 |
|
|
2022
Q2 | $8K | Sell |
2
-1
| -33% | -$7.15K | ﹤0.01% | 8283 |
|
|
2022
Q1 | $33K | Buy |
3
+2
| +200% | +$20.1K | ﹤0.01% | 6899 |
|
|
2021
Q4 | $10K | Buy |
+1
| New | +$13.5K | ﹤0.01% | 8761 |
|
|
2021
Q3 | – | Sell |
-1
| Closed | -$11.1K | – | 9148 |
|
|
2021
Q2 | $12K | Sell |
1
-6
| -86% | -$63.1K | ﹤0.01% | 7869 |
|
|
2021
Q1 | $63K | Buy |
+7
| New | +$68.2K | ﹤0.01% | 6323 |
|
|
2020
Q4 | – | Sell |
-1
| Closed | -$4K | – | 8399 |
|
|
2020
Q3 | $4K | Hold |
1
| – | – | ﹤0.01% | 7390 |
|
|
2020
Q2 | $16K | Buy |
+1
| New | +$15.3K | ﹤0.01% | 6688 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 7974 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 7135 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 6863 |
|
Other funds holding SGRX
UBS Group's SGRX Position: Q2 2026 in Review
UBS Group increased its SANGRIX INC. Class A Ordinary Shares (SGRX) stake by 80% in Q2 2026, buying an estimated $2.08K and bringing the position to 469 shares worth $2.93K. The position accounts for ﹤0.01% of the portfolio, ranked #9262.
UBS Group first reported a position in SGRX in Q2 2020 and has held it in 20 quarters since. The position peaked at $214K in Q3 2025. 5 funds tracked by Wall St. Rank hold SGRX as of Q2 2026.
- UBS Group held 469 shares of SANGRIX INC. Class A Ordinary Shares worth $2.93K as of Q2 2026.
- UBS Group bought 209 SANGRIX INC. Class A Ordinary Shares shares in Q2 2026, an estimated $2.08K.
- SANGRIX INC. Class A Ordinary Shares made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #9262 holding.
- UBS Group first reported a position in SANGRIX INC. Class A Ordinary Shares in Q2 2020 and has held it in 20 quarters since.
- UBS Group's SANGRIX INC. Class A Ordinary Shares position peaked at $214K in Q3 2025.
- 5 funds tracked by Wall St. Rank held SANGRIX INC. Class A Ordinary Shares as of Q2 2026.
Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.